Ranolazine
- Product NDC
- 67877-526
- 11-digit product format
- 678770526
- Labeler code
- 67877
- Product ID
- 67877-526_05aa3d63-f0b2-4aff-8c82-847eec936579
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranolazine
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA209953
- Marketing category
- ANDA
- Marketing start
- 2020-12-02
- Substance
- RANOLAZINE
- Active strength
- 1000 mg/1
- Pharmacologic classes
- Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209953-001 | RANOLAZINE | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | |
| A209953-002 | RANOLAZINE | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209953-001 | AB |
| A209953-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A209953-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A209953-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-11-30 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209953-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209953-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209953-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209953-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209953-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209953-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209953-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209953-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209953-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209953-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209953-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209953-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209953-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209953-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209953-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209953-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209953-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209953-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209953-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209953-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209953-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209953-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209953-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209953-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209953-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209953-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209953-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209953-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209953-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209953-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209953-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209953-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209953-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209953-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209953-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209953-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A209953-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A209953-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A209953-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A209953-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ranolazine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| RANOLAZINE | 1000 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| A6IEZ5M406 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4367aed1-e488-b72c-d0ec-178a4e054129 | Product name | 9 | 20250624 |
| ddc83a74-720a-4975-8550-c4bd979c9094 | Product name | 1 | 20221212 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67877-526-05 | Ranolazine | 500 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 500 | 6 | |
| 67877-526-38 | Ranolazine | 10 in 1 BLISTER PACK | TABLET, FILM COATED, EXTENDED RE | 10 | 6 | |
| 67877-526-38 | Ranolazine | 10 in 1 CARTON | TABLET, FILM COATED, EXTENDED RE | 10 | 6 | |
| 67877-526-60 | Ranolazine | 60 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 60 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67877-526-60 | EA - Each | 67877-526 | 120f6adf-67ca-414f-92b9-88e977f85188 | 1 | 2021-07-15 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ranolazine | RANOLAZINE | Major Pharmaceuticals | 6166c40c-4fbe-47c4-92e4-2dc5d3567a86 | 2026-06-09 | Warnings, Adverse reactions | 209953 ANDA209953 |
| Ranolazine | RANOLAZINE | AvPAK | e92350e8-5b0b-95d3-e053-2995a90a959b | 2026-01-09 | Warnings, Adverse reactions | 209953 ANDA209953 |
| Ranolazine | RANOLAZINE | Ascend Laboratories, LLC | 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | 2025-07-28 | Warnings, Adverse reactions | 209953 ANDA209953 67877-526 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 728231 | ranolazine 1000 MG 12HR Extended Release Oral Tablet | PSN | 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | 6 |
| 616749 | ranolazine 500 MG 12HR Extended Release Oral Tablet | PSN | 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | 6 |
| 728231 | 12 HR ranolazine 1000 MG Extended Release Oral Tablet | SCD | 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | 6 |
| 616749 | 12 HR ranolazine 500 MG Extended Release Oral Tablet | SCD | 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | 6 |
| 728231 | ranolazine 1000 MG 12 HR Extended Release Oral Tablet | SY | 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | 6 |
| 616749 | ranolazine 500 MG 12 HR Extended Release Oral Tablet | SY | 5b254a8e-db88-49be-bb48-e6d2847f8ab3 | 6 |
| 728231 | ranolazine 1000 MG 12HR Extended Release Oral Tablet | PSN | e92350e8-5b0b-95d3-e053-2995a90a959b | 2 |
| 616749 | ranolazine 500 MG 12HR Extended Release Oral Tablet | PSN | e92350e8-5b0b-95d3-e053-2995a90a959b | 2 |
| 728231 | 12 HR ranolazine 1000 MG Extended Release Oral Tablet | SCD | e92350e8-5b0b-95d3-e053-2995a90a959b | 2 |
| 616749 | 12 HR ranolazine 500 MG Extended Release Oral Tablet | SCD | e92350e8-5b0b-95d3-e053-2995a90a959b | 2 |
| 728231 | ranolazine 1000 MG 12 HR Extended Release Oral Tablet | SY | e92350e8-5b0b-95d3-e053-2995a90a959b | 2 |
| 616749 | ranolazine 500 MG 12 HR Extended Release Oral Tablet | SY | e92350e8-5b0b-95d3-e053-2995a90a959b | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67877-526-05 | 67877052605 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-526-05) | 2020-12-02 | 0000-00-00 | No | No | Current | |
| 67877-526-38 | 67877052638 | 10 BLISTER PACK in 1 CARTON (67877-526-38) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK | 10 blister pack | 2020-12-02 | 0000-00-00 | No | No | Current |
| 67877-526-60 | 67877052660 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-526-60) | 2020-12-02 | 0000-00-00 | No | No | Current |